---
schema_version: "secwatch.filing_event.v1"
accession: "0001851734-22-000581"
form_type: "8-K"
ticker: "NAGE"
cik: "0001386570"
company_name: "Niagen Bioscience, Inc."
filed_at: "2022-10-03T23:59:59+00:00"
generated_at: "2026-06-23T05:53:01.100156+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# ChromaDex forms China JV for Tru Niagen, sells $3.1M stock to insiders at $1.25/sh

## Summary
- Taikuk invests $1M for 11% non-voting stake in JV to commercialize Tru Niagen in China; Blue Hat registration required within 24 months.
- Prior Term Sheet with Crystal Lake and Pioneer Idea terminated; new structure approved by Audit Committee.
- Company sells 2.48M shares at $1.25 for $3.1M to existing holders including CEO Robert Fried; closing expected Oct 7, 2022.
- Shares unregistered, sold under Rule 506; Registration Rights Agreement provides for future resale registration.

## SEC filing metadata
- accession: 0001851734-22-000581
- form_type: 8-K
- ticker: NAGE
- cik: 0001386570
- company_name: Niagen Bioscience, Inc.
- filed_at: 2022-10-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 1.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1386570/000185173422000581/0001851734-22-000581-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1386570/000185173422000581/cdxc20220930_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001851734-22-000581
- JSON: https://secwatch.observer/filing/0001851734-22-000581.json
- Plain text: https://secwatch.observer/filing/0001851734-22-000581.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.